Showing the single result
MK-2866 (Ostarine) powder – 1000mg
What is MK-2866?
Originally designed as a treatment for osteoporosis, researchers have discovered many more possible applications. It is currently under research to combat a number of different conditions.
SARMS like ostarine (MK-2866) are specifically developed because they bind to he androgenic receptors (ARs) in more specific locations, mainly in bone and muscle tissue.
Benefits of Ostarine
MK-2866 is the safest and mildest SARM known. Therefore side effects seem to be pretty much non existent. The benefits of ostarine come from clinical research, as well as in the numerous anecdotal reports from users.
Prevent muscle wasting
First of all ostarine has the ability to prevent muscle wasting. This can have broad implications for the treatment of a whole range of illnesses that are known to cause a rapid loss of muscle tissue, but can also help in maintaining lean muscle mass during a caloric deficit.
Improve bone health and density
Combating the loss of muscle mass is by no means the only beneficial effect from this compound. It also has the potential to improve bone health by increasing bone mineral density. Ostarine was actually developed for the treatment of osteoporosis and other age related conditions that are known to cause a loss of bone mass. Based on the extensive research and anecdotal evidence, this compound seems to be very effective in this area.
Improve recovery in injuries
The most praised effect of ostarine is most likely the fact that it provides healing properties in injuries to bone and connective tissue. This means that it can improve recovery in fractures and other injuries in skeleton tissue.
Application Selective Androgen Receptor Modulator CAS 841205-47-8 Molecular Weight 389.334 g/mol Chemical Formula C19H14F3N3O3 Chemical Name (2S)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide Synonyms Ostarine, Enobosarm, MK-2866, MK2866
This product is strictly for laboratory and research purposes only.